Status: current, Primitive. Date: 30-Apr 2013. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 520531000036111 | intratracheal suspension dose form (AU qualifier) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 520541000036118 | intratracheal suspension | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| intratracheal suspension | Is a | form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| poractant alfa 120 mg/1.5 mL intratracheal suspension, vial | has manufactured dose form | True | intratracheal suspension | Inferred relationship | Some | |
| poractant alfa 240 mg/3 mL intratracheal suspension, vial | has manufactured dose form | True | intratracheal suspension | Inferred relationship | Some | |
| beractant 200 mg/8 mL intratracheal suspension, vial | has manufactured dose form | True | intratracheal suspension | Inferred relationship | Some | |
| Survanta 200 mg/8 mL intratracheal suspension, 8 mL vial | has manufactured dose form | True | intratracheal suspension | Inferred relationship | Some | |
| Curosurf 120 mg/1.5 mL intratracheal suspension, 1.5 mL vial | has manufactured dose form | True | intratracheal suspension | Inferred relationship | Some | |
| Curosurf 240 mg/3 mL intratracheal suspension, 3 mL vial | has manufactured dose form | True | intratracheal suspension | Inferred relationship | Some |
Reference Sets
Unit of use quantity reference set
FHIR